Brightseed Valuation, Funding & Investors

Sarborg is an artificial intelligence company focused on signature intelligence, using proprietary signature-analysis tools to evaluate biological, chemical, and industrial data for decision-making. Its work supports clinical asset evaluation in pharmaceuticals, including drug-repurposing analysis, and it has developed intellectual property such as solid-form and cocrystal assets and its AISignature Agent technology. Founded in 2024, the company also applies its signature-based analytics to industrial sectors beyond pharmaceuticals.

Inceptive is a biotechnology firm that engineers RNA molecules through deep learning models refined by high-throughput wet-lab experiments. Headquartered in South San Francisco, the company builds platforms for designing mRNA vaccines, gene therapies, and protein therapeutics. Its Evo 2.0 model generates novel RNA sequences with specified properties, accelerating development of treatments for infectious diseases and rare genetic disorders.

Vedanta Biosciences is a Cambridge, Massachusetts-based biotechnology company engineering microbiome immunotherapies for autoimmune, inflammatory, and infectious diseases. It develops consortia of live bacteria selected via proprietary assays from human donor samples, manufactured in cGMP facilities for oral administration. Vedanta's lead candidate VE202 advances in Phase 2 for graft-versus-host disease, with prior programs partnered to Janssen for Crohn's disease. Founded in 2010 as Seres spin-out, it maintains a library of over 1,000 bacterial strains and datasets from interventional studies.

Readline is a Shenzhen-headquartered biopharmaceutical firm pioneering enzyme-directed evolution for green manufacturing of active pharmaceutical ingredients. Specializing in peptides, carbohydrates, and nucleic acids, it supplies intermediates for medicines, cosmetics, animal feed, and biological pesticides, emphasizing sustainable production processes at industrial scale.

City Therapeutics engineers enhanced small-interfering RNAs for RNAi therapeutics targeting liver, muscle, and CNS diseases from its Boston headquarters. Founded in 2023, the biopharma advances a pipeline of siRNA candidates improving delivery and potency, backed by ARCH Venture Partners and Takeda. Its platform conjugates lipids and GalNAc for extrahepatic tissue targeting in metabolic and neuromuscular disorders.

Eviso SpA specializes in the supply of electricity for small and medium-sized enterprises, farms, shops and restaurants in low voltage and medium voltage. The coverage for the supply of electricity is active in all regions of Italy.

Harrison.ai is a Barongarook, Victoria-headquartered healthcare AI company developing deep learning tools for IVF embryo selection. The firm's IVY platform analyzes time-lapse video footage from incubators to predict implantation success rates. Harrison.ai integrates its software into fertility clinics' workflows in Australia and the United States, founded in 2018 to enhance clinical decision-making in reproductive medicine.

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

Winner Technology Co Inc Formerly Winner Information Technology Inc is a Chinese company engaged in the big data business. It provides offline consumer entity consumer data collection and analysis. The solutions offered by the company includes smart shopping, wisdom store and data service. Wisdom stores acquire consumer and product information by combining video identification, Beacon\Wi-Fi\RFID and other data collection technologies and multimedia means.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.